Browsing: Mortality Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for mortality risk analysis, commentary and insights.
Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.
New policies that will fuel future trades in the life settlement market continue to be issued in healthy volumes, but in real terms, are slowly contracting.
In today’s rapidly evolving insurance landscape, the arrival of AI in Life and Health underwriting and claims workflows is no longer a distant possibility – it’s already a reality.
Griffith Ballard will continue to operate from Cedar Rapids under its existing leadership team.
The past 12 months have seen significant developments that are likely to shape mortality models among defined benefit pensions scheme managers and sponsors alike, and possibly even have an impact on the pricing of de-risking deals.
The broader consequences of climate change are complex and far-reaching, with significant implications for human health, financial systems and the wider economy.
New PRA discussion paper provides insight into the UK regulator’s thinking on potential reforms to the existing ISPV regime.
The past four decades have brought revolutionary improvements in cancer care, transforming many forms of cancer from fatal diagnoses into chronic, manageable conditions.
For those in the longevity and mortality modelling game, 2025 has provided plenty of activity to keep the actuaries busy. Greg Winterton spoke to James Hadley, Senior Consultant at Barnett Waddingham, to learn more about what is front and centre of the conversation in his world as the year draws to a close.
A convergence of themes has contributed to the growth story of the US life and annuity market of the past few years.